Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 651–700 of 2,282 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05635149	Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer	unknown	—	100	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	Dec 2, 2022	clinicaltrials
NCT04077255	EGFR-targeted Therapy for Gastric Cancer	unknown	Phase 2	19	National Cancer Center, KoreaOTHER_GOV	1	Nov 30, 2022